A novel plasma proteomic computational model for predicting therapeutic benefit from immune checkpoint inhibitors in non-small cell lung cancer https://www.medrxiv.org/content/10.1101/2022.12.01.22282769
A novel plasma proteomic computational model for predicting therapeutic benefit from immune checkpoint inhibitors in non-small cell lung cancer https://www.medrxiv.org/content/10.1101/2022.12.01.22282769